(TXG) 10X Genomics - Ratings and Ratios

10x Genomics Inc, a pioneering life science technology company, specializes in developing and commercializing innovative instruments, consumables, and software designed to analyze complex biological systems. With a global presence spanning the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific, the company has established itself as a leading provider of cutting-edge solutions for the life sciences industry. Its product portfolio includes a range of instruments such as Chromium, Chromium Connect, and Chromium Controller, which are complemented by microfluidic chips, slides, reagents, and other consumables.

The company's single cell solutions, which operate on its Chromium instruments, offer a suite of applications including single cell gene expression, single cell gene expression flex, single cell immune profiling, and single cell Assay for Transposase Accessible Chromatin (ATAC) solution. These solutions enable researchers to measure gene activity and networks on a cell-by-cell basis, study the immune system, and understand the epigenetic state of cells. Furthermore, the single cell multiome ATAC + gene expression solution allows for the simultaneous analysis of both RNA and chromatin accessibility in a single cell, providing unparalleled insights into cellular biology.

In addition to its single cell solutions, 10x Genomics also offers the Visium platform, which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. The Xenium platform, designed for in situ analysis, further expands the company's capabilities in spatial genomics. By providing these innovative solutions, 10x Genomics serves a diverse range of customers, including academic institutions, government agencies, biopharmaceutical companies, biotechnology firms, and other research organizations. With its strong foundation in life science technology, the company continues to drive advancements in the field, empowering researchers to make new discoveries and gain a deeper understanding of complex biological systems.

Originally founded as 10X Technologies, Inc in 2012, the company changed its name to 10x Genomics, Inc in November 2014, reflecting its focus on genomics and life science technology. Headquartered in Pleasanton, California, 10x Genomics has established itself as a key player in the life sciences industry, with a web presence at https://www.10xgenomics.com and a common stock listed under the ISIN code US88025U1097, classified under the GICS Sub Industry: Life Sciences Tools & Services.